Cancer News

Is chemotherapy beneficial for non-small cell lung cancer patients?

A new large analysis showed that patients with stage IB non-small cell lung cancer lived longer with adjuvant chemotherapy treatment.

Surgery improved survival in lung cancer patients

Patients with late-stage, non-small cell lung cancer who had surgery lived longer than those who didn’t, a new data analysis reveals.

Better quality of life after surgery for mesothelioma patients

Patients with an aggressive type of cancer called malignant pleural mesothelioma improved their quality of life after surgery, a survey reveals.

Olaparib increased overall survival in relapsed ovarian cancer

Olaparib (Lynparza) induced positive patient outcomes in relapsed ovarian cancer patients, especially of the BRCAm mutation.

Immunotherapy blinatumomab brings hope to ALL patients

Immunotherapy drug blinatumomab extended patients life with relapsed acute lymphoblastic leukemia when compared to chemotherapy.

Aspirin may prevent colon cancer relapse

Aspirin can be used to reduce mortality among colon cancer survivors as it may prevent cancer relapse, a new and unique study reports.

Chemotherapy combo prolongs survival in pancreatic cancer

Treating pancreatic cancer patients with oral chemotherapy drug capecitabine with gemcitabine prolonged their survival without increasing toxicity.

Chemoradiation increased survival in elderly glioblastoma patients

Elderly glioblastoma patients lived longer after being treated with chemoradiation using temozolomide, new research reveals.

Breast cancer: lower risk of recurrence with hormone therapy

Postmenopausal breast cancer patients had a 34% lower risk of recurrence after receiving hormone therapy letrozole from 5 to 10 years, a new study shows.

US regulators approve lenvatinib and everolimus for kidney cancer

The combination of lenvatinib and everolimus received FDA approval for the treatment of advanced renal cell carcinoma following prior anti-angiogenetic therapy.

Better patient outcomes with stem-cell transplant in neuroblastoma

Adding a second autologous stem-cell transplant to treatment improved outcomes for children with high-risk neuroblastoma, a new research shows.

Daratumumab demonstrates efficacy against multiple myeloma

Adding daratumumab to a standard two-drug regimen reduced the risk of cancer progression in patients with recurrent or refractory multiple myeloma.

Tecentriq brings hope to untreated bladder cancer patients

Treating metastatic bladder cancer patients with Tecentriq resulted in tumor shrinkage with less toxic effects, researchers say.

Tackling chemo side effects with personalized exercise program

Exercise reduced symptoms of neuropathy due to chemotherapy in cancer patients, investigators report.

Ovarian Cancer: extended survival with hormonal maintenance therapy

Treating patients of low-grade serous carcinoma (LGSC) of the ovary or peritoneum with hormonal maintenance therapy improved progression-free survival.

The important role of mental health in cancer recovery

Colorectal cancer patients with depression at time of diagnosis are more likely to have very poor quality of life after treatment, a new research shows.

Ibrutinib gets EU approval for newly diagnosed CLL

EU regulators approved ibrutinib for the treatment of adult patients with previously untreated chronic lymphocytic leukemia (CLL).

PD-1 inhibitors hold promise for melanoma patients

In two studies, the PD-1 inhibitors pembrolizumab and nivolumab produced long-duration disease control and long-term survival for some melanoma patients.

FDA Approves Atezolizumab for advanced urothelial cancer

US regulators approved the PD-L1 inhibitor atezolizumab for the treatment of advanced urothelial cancer, the most common form of bladder cancer.

Pancreatic cancer: better long-term survival with surgery

Scientists found that a specific protocol of chemotherapy, radiation and aggressive surgery led to better long-term survival for pancreatic cancer patients.

Early screening can save lives in lung cancer

Screening patients with a high risk of developing lung cancer can identify early stage disease, improving greatly their survival rates.

Which treatment is more effective for stage II testicular cancer?

Scientists comparing treatment methods for stage II testicular cancer report that radiotherapy is more effective than chemotherapy.

Recent cancer diagnosis boosts mental health disorders

The risk of mental health disorders is increased during the first week of a cancer diagnosis, a new study reports.

What is the best available treatment for soft tissue sarcoma?

Pulmonary metastasectomy was associated to prolonged survival in patients with metastatic soft tissue sarcoma, a new data analysis shows.

Chemoradiotherapy or chemotherapy against pancreatic cancer?

Scientists comparing chemoradiotherapy with chemotherapy for the treatment of locally advanced pancreatic cancer report no added survival benefit of chemoradiotherapy.

Immunotherapy and radiation: synergy against melanoma

Treating advanced melanoma patients with radiation combined with immunotherapy induces better results against melanoma, a research shows.

Palliative care helps families facing cancer

Palliative care showed to improve caregivers’ quality of life and mood creating a powerful positive feedback loop in families facing cancer.

How can robotic surgery benefit obese prostate cancer patients?

Robotic surgery to remove the prostate reduced risk of blood loss in obese prostate cancer patients, a new study reveals.

Pembrolizumab increases long-term survival in advanced myeloma

Advanced melanoma patients lived longer after being treated with pembrolizumab regardless of whether they received previous treatments, a study shows.

Nivolumab gets US accelerated approval for Hodgkins lymphoma

US regulators granted accelerated approval to nivolumab for the treatment of patients with classical Hodgkin lymphoma.

Login to your account

Did you forget your password?